Explore News
-
GLP-1 Medications Reduce Cardiovascular Risk by 20%
A landmark global study finds that GLP-1 drugs significantly lower the risk of heart attacks,…
-
Ozempic Weight Loss Tied to Major Health Benefits, Study Reveals
New research shows that patients who lost the most weight on GLP-1 drugs like Ozempic…
-
Ozempic Cuts Blood Pressure by 5 Points in New Study
A growing body of evidence suggests that GLP-1 receptor agonists, originally developed for type 2…
-
GLP-1 Drugs May Cut Breast Cancer Recurrence Risk by 38%
A landmark study reveals that diabetes and obesity drugs like Ozempic may significantly improve survival…
-
Medicare to Cover GLP-1s for Weight Loss in 2024 Pilot
A new federal pilot program will test Medicare coverage of GLP-1 drugs like semaglutide and…
-
70% of Patients Lose 15% Body Weight on New Drugs
Drugs like Wegovy and Mounjaro mimic gut hormones to regulate hunger and insulin, offering unprecedented…
-
10% of People May Not Benefit from GLP-1 Drugs
Emerging research reveals that genetic variation significantly influences how well patients respond to GLP-1 receptor…
-
New Study: 78% Drop in Food Noise With Drug and Therapy Combo
Combining GLP-1 drugs with behavioral therapy significantly reduces intrusive food thoughts, a new study finds,…
-
Next-Gen GLP-1 Drug Survodutide Shows 16% More Weight Loss Than Zepbound
A phase 3 trial reveals survodutide, a dual GLP-1 and glucagon receptor agonist, led to…
-
Why GLP-1 Medications Like Ozempic Have Unreported Side Effects
New research uncovers overlooked side effects of GLP-1 medications
